Zacks Research Comments on NewGenIvf Group FY2026 Earnings

NewGenIvf Group Limited (NASDAQ:NIVF) – Analysts at Zacks Research issued their FY2026 EPS estimates for NewGenIvf Group in a research report issued to clients and investors on Wednesday, April 1st. Zacks Research analyst B. Sorensen anticipates that the company will post earnings of $4.74 per share for the year. Zacks Research also issued estimates for NewGenIvf Group’s FY2027 earnings at $9.34 EPS and FY2028 earnings at $14.70 EPS.

Several other research firms have also issued reports on NIVF. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, December 6th. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Wednesday, January 28th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, NewGenIvf Group presently has an average rating of “Sell”.

NewGenIvf Group Stock Performance

NASDAQ NIVF opened at $2.13 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.37 and a current ratio of 3.43. The firm has a 50-day moving average of $3.18 and a 200-day moving average of $31.63. NewGenIvf Group has a 52-week low of $1.52 and a 52-week high of $4,440.00.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.